ナノメディシンの世界市場、ナノ分子タイプ別(ナノ粒子、ナノシェル、ナノデバイス、ナノチューブ)、ナノ粒子タイプ別(ポリマーベース、脂質ベース、ナノクリスタル、無機、その他)、用途別(ドラッグデリバリー、ワクチン、診断イメージング、再生医療、その他) 疾患適応症別(腫瘍性疾患、感染症、整形外科疾患、循環器疾患、その他)、地域別、競争予測・機会、2027年Global Nanomedicine Market, By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes), By Nanoparticle Type (Polymer-based, Lipid-based, Nanocrystals, Inorganic, Others), By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others) By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others), By Region and Competition Forecast & Opportunities, 2027 世界のナノメディシン市場は、予測期間である2023年から2027年にかけて8.28%という驚異的なCAGRで成長し、2027年には2億4265万5100米ドルに達すると予想されます。この市場を牽引しているのは、医療費の増大や個... もっと見る
サマリー世界のナノメディシン市場は、予測期間である2023年から2027年にかけて8.28%という驚異的なCAGRで成長し、2027年には2億4265万5100米ドルに達すると予想されます。この市場を牽引しているのは、医療費の増大や個別化医療に対する需要の高まりといった要因です。がんや心血管疾患などの慢性疾患や生活習慣病の世界的な大流行は、さまざまなヘルスケアアプリケーションにおけるナノメディシンの適用を加速しています。また、薬物送達のための新しい解決策を見つけ、薬物の有効性を高めるために、公的機関や民間企業が研究開発活動に対して多額の投資を行っていることも、予測期間中に世界のナノメディシン市場に有利な成長機会を生み出すと期待されています。ナノメディシンは、体内での薬の代謝を促進するため、がん、認知症、糖尿病などの慢性疾患の治療に非常に有効であると考えられています。ナノメディシンは、体内で薬の代謝を促進するため、がんや認知症、糖尿病などの慢性疾患の治療に非常に有効であると考えられています。DNAプローブ、ナノセンサー、ナノ粒子ベースのイメージング剤などのナノメディカル製品が市場に出回るようになり、需要が高まっています。しかし、ナノメディシンの製造プロセスや研究開発活動に関連する高コストが、予測期間における世界のナノメディシン市場の妨げになる可能性があります。 世界のナノメディシン市場は、ナノ分子タイプ、ナノ粒子タイプ、アプリケーション、疾患適応、地域分布、競争環境に分けられます。アプリケーションに基づき、ナノメディシン市場はドラッグデリバリー、ワクチン、診断イメージング、再生医療、その他に分けられる。ドラッグデリバリーアプリケーションは2021年に市場を支配し、市場全体のシェアの30.23%を獲得しました。このセグメントは今後5年間、その優位性を維持すると予想されます。ドラッグデリバリーアプリケーションにおけるナノメディシンの利点に関する意識の高まりと、疾患の有病率の増加が、ドラッグデリバリーアプリケーション向けナノメディシンの需要を牽引しています。 世界のナノメディシン市場で活動している主な市場プレイヤーは、Pfizer Inc.、Janssen Pharmaceuticals、Sanofi S.A.、Amgen Inc.、Moderna、Novo Nordisk A/S、Genentech、Inc、Celgene Corporation、Vifor Pharma Group、Teva Pharmaceutical Industries Ltd.など。 本レポートで考慮した年数 歴史的年数:2017年~2020年 基準年:2021年 予定年:2022年 予測期間:2023-2027年 本調査の目的 - 2017年から2021年までの世界のナノメディシン市場の過去の成長と市場規模を分析すること。 - 2023年から2027年までの世界のナノメディシン市場の市場規模および2027年までの成長率を推定・予測する。 - 世界のナノメディシン市場をナノ分子タイプ、ナノ粒子タイプ、用途、疾患適応、地域分布、競合環境に分類し予測する。 - 世界のナノメディシン市場の促進要因と課題を特定する。 - 世界のナノメディシン市場における事業拡大、新製品発売、合併、買収などの競争展開を検討する。 - 世界のナノメディシン市場の価格分析を行う。 - 世界のナノメディシン市場で活動する主要企業のプロファイルを特定し分析する。 TechSci Researchは、この調査のために一次調査と徹底的な二次調査の両方を実施しました。最初に、TechSci Researchは、世界中の主要なナノメディシンメーカーのリストを入手しました。その後、TechSci Researchは特定された企業に対して一次調査アンケートを実施しました。インタビュー中に、回答者は競合他社についても尋ねられた。この手法により、TechSci Researchは、二次調査の制限により特定できなかったナノメディシンメーカーを含めることができました。TechSci Research社は、世界のナノメディシン市場で活動するすべての主要企業のナノメディシンメーカー、流通チャネル、存在を世界中で分析しました。 TechSci Research社は、ボトムアップアプローチで世界のナノメディシン市場規模を算出し、様々な地域のデータが記録され、将来的な予測がなされました。TechSci Research社は、これらの値を業界の専門家や企業の代表者から入手し、適切な全体的な市場規模を得るために、これらの製品タイプやアプリケーションの履歴データを分析することによって外部で検証しました。また、企業のウェブサイト、ニュース記事、プレスリリース、企業の年次報告書、投資家のプレゼンテーション、財務報告書などのさまざまな二次資料もTechSci Researchによって調査されました。 主な対象読者 - ナノメディシンメーカー/サプライヤー/ディストリビューター - 規制当局や政策立案者などの政府機関 - ナノメディシンに関連する団体、フォーラム、アライアンスなど - 市場調査会社、コンサルティング会社 本調査は、ナノメディシンのメーカー、サプライヤー、流通業者などの業界関係者にとって重要ないくつかの重要な質問に対する答えを提供するのに有用である。本レポートは、関係者が投資を戦略化し、新たな市場機会を活用するのに役立つだろう。 レポートの範囲です: 本レポートでは、世界のナノメディシン市場を以下のカテゴリーに分類し、さらに以下に詳述する業界動向も合わせて紹介しています: - ナノメディシン市場、ナノ分子タイプ別: oナノ粒子 o ナノシェル o ナノデバイス o ナノチューブ - ナノメディシン市場、ナノ粒子タイプ別: o ポリマーベース o 脂質系 o ナノクリスタル o 無機質 o その他 - ナノメディシン市場、アプリケーション別 o ドラッグデリバリー o ワクチン o 画像診断 o 再生医療 o その他 - ナノメディシン市場、疾患適応別: オンコロジー疾患 o 感染症 o 整形外科疾患 o 循環器系疾患 o その他 - ナノメディシン市場、地域別 o 北米 米国 カナダ メキシコ オーヨーロッパ ドイツ フランス イギリス イタリア スペイン デンマーク o アジア太平洋 中国 日本 インド オーストラリア 韓国 マレーシア ベトナム o 南米 ブラジル アルゼンチン コロンビア o 中東・アフリカ トルコ イスラエル 南アフリカ サウジアラビア UAE クウェート 競合他社の状況 企業プロフィール:世界のナノメディシン市場に存在する主要企業の詳細な分析。 利用可能なカスタマイズ: TechSci Researchは、与えられた市場データをもとに、企業の特定のニーズに応じてカスタマイズを提供します。このレポートでは、以下のカスタマイズオプションが利用可能です: 会社情報 - 追加市場プレイヤー(最大5名)の詳細分析およびプロファイリング。 目次1. Product Overview2. Research Methodology 3. Executive Summary 4. Impact of COVID-19 on Global Nanomedicine Market 5. Voice of Customer 5.1. Factors Increasing the demand for Nanomedicine 5.2. Preference, By Nanomolecule Type 5.3. Demand for Nanomedicine, By Indication 5.4. Brand Awareness 6. Global Nanomedicine Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes) 6.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others) 6.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others) 6.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others) 6.2.4. By Company (2021) 6.2.5. By Region 6.3. Market Map 7. North America Nanomedicine Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes) 7.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others) 7.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others) 7.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others) 7.2.4. By Country 7.3. North America: Country Analysis 7.3.1. United States Nanomedicine Market Outlook 7.3.1.1. Market Size & Forecast 7.3.1.1.1. By Value 7.3.1.2. Market Share & Forecast 7.3.1.2.1. By Nanomolecule Type 7.3.1.2.1.1. By Nanoparticle Type 7.3.1.2.2. By Application 7.3.1.2.3. By Disease Indication 7.3.2. Canada Nanomedicine Market Outlook 7.3.2.1. Market Size & Forecast 7.3.2.1.1. By Value 7.3.2.2. Market Share & Forecast 7.3.2.2.1. By Nanomolecule Type 7.3.2.2.1.1. By Nanoparticle Type 7.3.2.2.2. By Application 7.3.2.2.3. By Disease Indication 7.3.3. Mexico Nanomedicine Market Outlook 7.3.3.1. Market Size & Forecast 7.3.3.1.1. By Value 7.3.3.2. Market Share & Forecast 7.3.3.2.1. By Nanomolecule Type 7.3.3.2.1.1. By Nanoparticle Type 7.3.3.2.2. By Application 7.3.3.2.3. By Disease Indication 8. Europe Nanomedicine Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value 8.2. Market Share & Forecast 8.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes) 8.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others) 8.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others) 8.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others) 8.2.4. By Country 8.3. Europe: Country Analysis 8.3.1. Germany Nanomedicine Market Outlook 8.3.1.1. Market Size & Forecast 8.3.1.1.1. By Value 8.3.1.2. Market Share & Forecast 8.3.1.2.1. By Nanomolecule Type 8.3.1.2.1.1. By Nanoparticle Type 8.3.1.2.2. By Application 8.3.1.2.3. By Disease Indication 8.3.2. France Nanomedicine Market Outlook 8.3.2.1. Market Size & Forecast 8.3.2.1.1. By Value 8.3.2.2. Market Share & Forecast 8.3.2.2.1. By Nanomolecule Type 8.3.2.2.1.1. By Nanoparticle Type 8.3.2.2.2. By Application 8.3.2.2.3. By Disease Indication 8.3.3. United Kingdom Nanomedicine Market Outlook 8.3.3.1. Market Size & Forecast 8.3.3.1.1. By Value 8.3.3.2. Market Share & Forecast 8.3.3.2.1. By Nanomolecule Type 8.3.3.2.1.1. By Nanoparticle Type 8.3.3.2.2. By Application 8.3.3.2.3. By Disease Indication 8.3.4. Italy Nanomedicine Market Outlook 8.3.4.1. Market Size & Forecast 8.3.4.1.1. By Value 8.3.4.2. Market Share & Forecast 8.3.4.2.1. By Nanomolecule Type 8.3.4.2.1.1. By Nanoparticle Type 8.3.4.2.2. By Application 8.3.4.2.3. By Disease Indication 8.3.5. Spain Nanomedicine Market Outlook 8.3.5.1. Market Size & Forecast 8.3.5.1.1. By Value 8.3.5.2. Market Share & Forecast 8.3.5.2.1. By Nanomolecule Type 8.3.5.2.1.1. By Nanoparticle Type 8.3.5.2.2. By Application 8.3.5.2.3. By Disease Indication 8.3.6. Denmark Nanomedicine Market Outlook 8.3.6.1. Market Size & Forecast 8.3.6.1.1. By Value 8.3.6.2. Market Share & Forecast 8.3.6.2.1. By Nanomolecule Type 8.3.6.2.1.1. By Nanoparticle Type 8.3.6.2.2. By Application 8.3.6.2.3. By Disease Indication 9. Asia Pacific Nanomedicine Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value 9.2. Market Share & Forecast 9.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes) 9.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others) 9.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others) 9.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others) 9.2.4. By Country 9.3. Asia Pacific: Country Analysis 9.3.1. China Nanomedicine Market Outlook 9.3.1.1. Market Size & Forecast 9.3.1.1.1. By Value 9.3.1.2. Market Share & Forecast 9.3.1.2.1. By Nanomolecule Type 9.3.1.2.1.1. By Nanoparticle Type 9.3.1.2.2. By Application 9.3.1.2.3. By Disease Indication 9.3.2. Japan Nanomedicine Market Outlook 9.3.2.1. Market Size & Forecast 9.3.2.1.1. By Value 9.3.2.2. Market Share & Forecast 9.3.2.2.1. By Nanomolecule Type 9.3.2.2.1.1. By Nanoparticle Type 9.3.2.2.2. By Application 9.3.2.2.3. By Disease Indication 9.3.3. India Nanomedicine Market Outlook 9.3.3.1. Market Size & Forecast 9.3.3.1.1. By Value 9.3.3.2. Market Share & Forecast 9.3.3.2.1. By Nanomolecule Type 9.3.3.2.1.1. By Nanoparticle Type 9.3.3.2.2. By Application 9.3.3.2.3. By Disease Indication 9.3.4. Australia Nanomedicine Market Outlook 9.3.4.1. Market Size & Forecast 9.3.4.1.1. By Value 9.3.4.2. Market Share & Forecast 9.3.4.2.1. By Nanomolecule Type 9.3.4.2.1.1. By Nanoparticle Type 9.3.4.2.2. By Application 9.3.4.2.3. By Disease Indication 9.3.5. South Korea Nanomedicine Market Outlook 9.3.5.1. Market Size & Forecast 9.3.5.1.1. By Value 9.3.5.2. Market Share & Forecast 9.3.5.2.1. By Nanomolecule Type 9.3.5.2.1.1. By Nanoparticle Type 9.3.5.2.2. By Application 9.3.5.2.3. By Disease Indication 9.3.6. Malaysia Nanomedicine Market Outlook 9.3.6.1. Market Size & Forecast 9.3.6.1.1. By Value 9.3.6.2. Market Share & Forecast 9.3.6.2.1. By Nanomolecule Type 9.3.6.2.1.1. By Nanoparticle Type 9.3.6.2.2. By Application 9.3.6.2.3. By Disease Indication 9.3.7. Vietnam Nanomedicine Market Outlook 9.3.7.1. Market Size & Forecast 9.3.7.1.1. By Value 9.3.7.2. Market Share & Forecast 9.3.7.2.1. By Nanomolecule Type 9.3.7.2.1.1. By Nanoparticle Type 9.3.7.2.2. By Application 9.3.7.2.3. By Disease Indication 10. South America Nanomedicine Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes) 10.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others) 10.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others) 10.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others) 10.2.4. By Country 10.3. South America: Country Analysis 10.3.1. Brazil Nanomedicine Market Outlook 10.3.1.1. Market Size & Forecast 10.3.1.1.1. By Value 10.3.1.2. Market Share & Forecast 10.3.1.2.1. By Nanomolecule Type 10.3.1.2.1.1. By Nanoparticle Type 10.3.1.2.2. By Application 10.3.1.2.3. By Disease Indication 10.3.2. Argentina Nanomedicine Market Outlook 10.3.2.1. Market Size & Forecast 10.3.2.1.1. By Value 10.3.2.2. Market Share & Forecast 10.3.2.2.1. By Nanomolecule Type 10.3.2.2.1.1. By Nanoparticle Type 10.3.2.2.2. By Application 10.3.2.2.3. By Disease Indication 10.3.3. Colombia Nanomedicine Market Outlook 10.3.3.1. Market Size & Forecast 10.3.3.1.1. By Value 10.3.3.2. Market Share & Forecast 10.3.3.2.1. By Nanomolecule Type 10.3.3.2.1.1. By Nanoparticle Type 10.3.3.2.2. By Application 10.3.3.2.3. By Disease Indication 11. Middle East and Africa Nanomedicine Market Outlook 11.1. Market Size & Forecast 11.1.1. By Value 11.2. Market Share & Forecast 11.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes) 11.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others) 11.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others) 11.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others) 11.2.4. By Country 11.3. Middle East and Africa: Country Analysis 11.3.1. Turkey Nanomedicine Market Outlook 11.3.1.1. Market Size & Forecast 11.3.1.1.1. By Value 11.3.1.2. Market Share & Forecast 11.3.1.2.1. By Nanomolecule Type 11.3.1.2.1.1. By Nanoparticle Type 11.3.1.2.2. By Application 11.3.1.2.3. By Disease Indication 11.3.2. Israel Nanomedicine Market Outlook 11.3.2.1. Market Size & Forecast 11.3.2.1.1. By Value 11.3.2.2. Market Share & Forecast 11.3.2.2.1. By Nanomolecule Type 11.3.2.2.1.1. By Nanoparticle Type 11.3.2.2.2. By Application 11.3.2.2.3. By Disease Indication 11.3.3. South Africa Nanomedicine Market Outlook 11.3.3.1. Market Size & Forecast 11.3.3.1.1. By Value 11.3.3.2. Market Share & Forecast 11.3.3.2.1. By Nanomolecule Type 11.3.3.2.1.1. By Nanoparticle Type 11.3.3.2.2. By Application 11.3.3.2.3. By Disease Indication 11.3.4. Saudi Arabia Nanomedicine Market Outlook 11.3.4.1. Market Size & Forecast 11.3.4.1.1. By Value 11.3.4.2. Market Share & Forecast 11.3.4.2.1. By Nanomolecule Type 11.3.4.2.1.1. By Nanoparticle Type 11.3.4.2.2. By Application 11.3.4.2.3. By Disease Indication 11.3.5. UAE Nanomedicine Market Outlook 11.3.5.1. Market Size & Forecast 11.3.5.1.1. By Value 11.3.5.2. Market Share & Forecast 11.3.5.2.1. By Nanomolecule Type 11.3.5.2.1.1. By Nanoparticle Type 11.3.5.2.2. By Application 11.3.5.2.3. By Disease Indication 11.3.6. Kuwait Nanomedicine Market Outlook 11.3.6.1. Market Size & Forecast 11.3.6.1.1. By Value 11.3.6.2. Market Share & Forecast 11.3.6.2.1. By Nanomolecule Type 11.3.6.2.1.1. By Nanoparticle Type 11.3.6.2.2. By Application 11.3.6.2.3. By Disease Indication 12. Market Dynamics 12.1. Drivers 12.2. Challenges 13. Market Trends and Developments 14. Competitive Landscape 14.1. Pfizer Inc. 14.2. Janssen Pharmaceuticals 14.3. Sanofi S.A. 14.4. Amgen Inc. 14.5. Moderna, Inc. 14.6. Novo Nordisk A/S 14.7. Genentech, Inc 14.8. Celgene Corporation 14.9. Vifor Pharma Ltd. 14.10. Teva Pharmaceutical Industries Ltd. 15. Strategic Recommendations
SummaryThe global nanomedicine market is expected to grow at an impressive CAGR of 8.28% in the forecast period, 2023-2027, to reach USD242655.19 million by 2027. The market is driven by the factors such as the growing healthcare expenditure and increased demand for personalized medicines. The massive prevalence of chronic and lifestyle disorders such as cancer and cardiovascular diseases across the globe is accelerating the application of nanomedicine in various healthcare applications. Also, the high-end investments in research and development activities by public and private players to find novel solutions for drug delivery and increase the effectiveness of drugs are expected to create lucrative growth opportunities for the global nanomedicine market in the forecast period. Table of Contents1. Product Overview2. Research Methodology 3. Executive Summary 4. Impact of COVID-19 on Global Nanomedicine Market 5. Voice of Customer 5.1. Factors Increasing the demand for Nanomedicine 5.2. Preference, By Nanomolecule Type 5.3. Demand for Nanomedicine, By Indication 5.4. Brand Awareness 6. Global Nanomedicine Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes) 6.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others) 6.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others) 6.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others) 6.2.4. By Company (2021) 6.2.5. By Region 6.3. Market Map 7. North America Nanomedicine Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes) 7.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others) 7.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others) 7.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others) 7.2.4. By Country 7.3. North America: Country Analysis 7.3.1. United States Nanomedicine Market Outlook 7.3.1.1. Market Size & Forecast 7.3.1.1.1. By Value 7.3.1.2. Market Share & Forecast 7.3.1.2.1. By Nanomolecule Type 7.3.1.2.1.1. By Nanoparticle Type 7.3.1.2.2. By Application 7.3.1.2.3. By Disease Indication 7.3.2. Canada Nanomedicine Market Outlook 7.3.2.1. Market Size & Forecast 7.3.2.1.1. By Value 7.3.2.2. Market Share & Forecast 7.3.2.2.1. By Nanomolecule Type 7.3.2.2.1.1. By Nanoparticle Type 7.3.2.2.2. By Application 7.3.2.2.3. By Disease Indication 7.3.3. Mexico Nanomedicine Market Outlook 7.3.3.1. Market Size & Forecast 7.3.3.1.1. By Value 7.3.3.2. Market Share & Forecast 7.3.3.2.1. By Nanomolecule Type 7.3.3.2.1.1. By Nanoparticle Type 7.3.3.2.2. By Application 7.3.3.2.3. By Disease Indication 8. Europe Nanomedicine Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value 8.2. Market Share & Forecast 8.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes) 8.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others) 8.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others) 8.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others) 8.2.4. By Country 8.3. Europe: Country Analysis 8.3.1. Germany Nanomedicine Market Outlook 8.3.1.1. Market Size & Forecast 8.3.1.1.1. By Value 8.3.1.2. Market Share & Forecast 8.3.1.2.1. By Nanomolecule Type 8.3.1.2.1.1. By Nanoparticle Type 8.3.1.2.2. By Application 8.3.1.2.3. By Disease Indication 8.3.2. France Nanomedicine Market Outlook 8.3.2.1. Market Size & Forecast 8.3.2.1.1. By Value 8.3.2.2. Market Share & Forecast 8.3.2.2.1. By Nanomolecule Type 8.3.2.2.1.1. By Nanoparticle Type 8.3.2.2.2. By Application 8.3.2.2.3. By Disease Indication 8.3.3. United Kingdom Nanomedicine Market Outlook 8.3.3.1. Market Size & Forecast 8.3.3.1.1. By Value 8.3.3.2. Market Share & Forecast 8.3.3.2.1. By Nanomolecule Type 8.3.3.2.1.1. By Nanoparticle Type 8.3.3.2.2. By Application 8.3.3.2.3. By Disease Indication 8.3.4. Italy Nanomedicine Market Outlook 8.3.4.1. Market Size & Forecast 8.3.4.1.1. By Value 8.3.4.2. Market Share & Forecast 8.3.4.2.1. By Nanomolecule Type 8.3.4.2.1.1. By Nanoparticle Type 8.3.4.2.2. By Application 8.3.4.2.3. By Disease Indication 8.3.5. Spain Nanomedicine Market Outlook 8.3.5.1. Market Size & Forecast 8.3.5.1.1. By Value 8.3.5.2. Market Share & Forecast 8.3.5.2.1. By Nanomolecule Type 8.3.5.2.1.1. By Nanoparticle Type 8.3.5.2.2. By Application 8.3.5.2.3. By Disease Indication 8.3.6. Denmark Nanomedicine Market Outlook 8.3.6.1. Market Size & Forecast 8.3.6.1.1. By Value 8.3.6.2. Market Share & Forecast 8.3.6.2.1. By Nanomolecule Type 8.3.6.2.1.1. By Nanoparticle Type 8.3.6.2.2. By Application 8.3.6.2.3. By Disease Indication 9. Asia Pacific Nanomedicine Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value 9.2. Market Share & Forecast 9.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes) 9.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others) 9.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others) 9.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others) 9.2.4. By Country 9.3. Asia Pacific: Country Analysis 9.3.1. China Nanomedicine Market Outlook 9.3.1.1. Market Size & Forecast 9.3.1.1.1. By Value 9.3.1.2. Market Share & Forecast 9.3.1.2.1. By Nanomolecule Type 9.3.1.2.1.1. By Nanoparticle Type 9.3.1.2.2. By Application 9.3.1.2.3. By Disease Indication 9.3.2. Japan Nanomedicine Market Outlook 9.3.2.1. Market Size & Forecast 9.3.2.1.1. By Value 9.3.2.2. Market Share & Forecast 9.3.2.2.1. By Nanomolecule Type 9.3.2.2.1.1. By Nanoparticle Type 9.3.2.2.2. By Application 9.3.2.2.3. By Disease Indication 9.3.3. India Nanomedicine Market Outlook 9.3.3.1. Market Size & Forecast 9.3.3.1.1. By Value 9.3.3.2. Market Share & Forecast 9.3.3.2.1. By Nanomolecule Type 9.3.3.2.1.1. By Nanoparticle Type 9.3.3.2.2. By Application 9.3.3.2.3. By Disease Indication 9.3.4. Australia Nanomedicine Market Outlook 9.3.4.1. Market Size & Forecast 9.3.4.1.1. By Value 9.3.4.2. Market Share & Forecast 9.3.4.2.1. By Nanomolecule Type 9.3.4.2.1.1. By Nanoparticle Type 9.3.4.2.2. By Application 9.3.4.2.3. By Disease Indication 9.3.5. South Korea Nanomedicine Market Outlook 9.3.5.1. Market Size & Forecast 9.3.5.1.1. By Value 9.3.5.2. Market Share & Forecast 9.3.5.2.1. By Nanomolecule Type 9.3.5.2.1.1. By Nanoparticle Type 9.3.5.2.2. By Application 9.3.5.2.3. By Disease Indication 9.3.6. Malaysia Nanomedicine Market Outlook 9.3.6.1. Market Size & Forecast 9.3.6.1.1. By Value 9.3.6.2. Market Share & Forecast 9.3.6.2.1. By Nanomolecule Type 9.3.6.2.1.1. By Nanoparticle Type 9.3.6.2.2. By Application 9.3.6.2.3. By Disease Indication 9.3.7. Vietnam Nanomedicine Market Outlook 9.3.7.1. Market Size & Forecast 9.3.7.1.1. By Value 9.3.7.2. Market Share & Forecast 9.3.7.2.1. By Nanomolecule Type 9.3.7.2.1.1. By Nanoparticle Type 9.3.7.2.2. By Application 9.3.7.2.3. By Disease Indication 10. South America Nanomedicine Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes) 10.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others) 10.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others) 10.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others) 10.2.4. By Country 10.3. South America: Country Analysis 10.3.1. Brazil Nanomedicine Market Outlook 10.3.1.1. Market Size & Forecast 10.3.1.1.1. By Value 10.3.1.2. Market Share & Forecast 10.3.1.2.1. By Nanomolecule Type 10.3.1.2.1.1. By Nanoparticle Type 10.3.1.2.2. By Application 10.3.1.2.3. By Disease Indication 10.3.2. Argentina Nanomedicine Market Outlook 10.3.2.1. Market Size & Forecast 10.3.2.1.1. By Value 10.3.2.2. Market Share & Forecast 10.3.2.2.1. By Nanomolecule Type 10.3.2.2.1.1. By Nanoparticle Type 10.3.2.2.2. By Application 10.3.2.2.3. By Disease Indication 10.3.3. Colombia Nanomedicine Market Outlook 10.3.3.1. Market Size & Forecast 10.3.3.1.1. By Value 10.3.3.2. Market Share & Forecast 10.3.3.2.1. By Nanomolecule Type 10.3.3.2.1.1. By Nanoparticle Type 10.3.3.2.2. By Application 10.3.3.2.3. By Disease Indication 11. Middle East and Africa Nanomedicine Market Outlook 11.1. Market Size & Forecast 11.1.1. By Value 11.2. Market Share & Forecast 11.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes) 11.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others) 11.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others) 11.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others) 11.2.4. By Country 11.3. Middle East and Africa: Country Analysis 11.3.1. Turkey Nanomedicine Market Outlook 11.3.1.1. Market Size & Forecast 11.3.1.1.1. By Value 11.3.1.2. Market Share & Forecast 11.3.1.2.1. By Nanomolecule Type 11.3.1.2.1.1. By Nanoparticle Type 11.3.1.2.2. By Application 11.3.1.2.3. By Disease Indication 11.3.2. Israel Nanomedicine Market Outlook 11.3.2.1. Market Size & Forecast 11.3.2.1.1. By Value 11.3.2.2. Market Share & Forecast 11.3.2.2.1. By Nanomolecule Type 11.3.2.2.1.1. By Nanoparticle Type 11.3.2.2.2. By Application 11.3.2.2.3. By Disease Indication 11.3.3. South Africa Nanomedicine Market Outlook 11.3.3.1. Market Size & Forecast 11.3.3.1.1. By Value 11.3.3.2. Market Share & Forecast 11.3.3.2.1. By Nanomolecule Type 11.3.3.2.1.1. By Nanoparticle Type 11.3.3.2.2. By Application 11.3.3.2.3. By Disease Indication 11.3.4. Saudi Arabia Nanomedicine Market Outlook 11.3.4.1. Market Size & Forecast 11.3.4.1.1. By Value 11.3.4.2. Market Share & Forecast 11.3.4.2.1. By Nanomolecule Type 11.3.4.2.1.1. By Nanoparticle Type 11.3.4.2.2. By Application 11.3.4.2.3. By Disease Indication 11.3.5. UAE Nanomedicine Market Outlook 11.3.5.1. Market Size & Forecast 11.3.5.1.1. By Value 11.3.5.2. Market Share & Forecast 11.3.5.2.1. By Nanomolecule Type 11.3.5.2.1.1. By Nanoparticle Type 11.3.5.2.2. By Application 11.3.5.2.3. By Disease Indication 11.3.6. Kuwait Nanomedicine Market Outlook 11.3.6.1. Market Size & Forecast 11.3.6.1.1. By Value 11.3.6.2. Market Share & Forecast 11.3.6.2.1. By Nanomolecule Type 11.3.6.2.1.1. By Nanoparticle Type 11.3.6.2.2. By Application 11.3.6.2.3. By Disease Indication 12. Market Dynamics 12.1. Drivers 12.2. Challenges 13. Market Trends and Developments 14. Competitive Landscape 14.1. Pfizer Inc. 14.2. Janssen Pharmaceuticals 14.3. Sanofi S.A. 14.4. Amgen Inc. 14.5. Moderna, Inc. 14.6. Novo Nordisk A/S 14.7. Genentech, Inc 14.8. Celgene Corporation 14.9. Vifor Pharma Ltd. 14.10. Teva Pharmaceutical Industries Ltd. 15. Strategic Recommendations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
TechSci Research社のヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD(medicine)の最新刊レポート
よくあるご質問TechSci Research社はどのような調査会社ですか?テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|